|
|||||
|
|

Semiconductor photomask manufacturer Photronics (NASDAQ:PLAB) announced better-than-expected revenue in Q3 CY2025, but sales fell by 3.1% year on year to $215.8 million. On top of that, next quarter’s revenue guidance ($221 million at the midpoint) was surprisingly good and 6.7% above what analysts were expecting. Its non-GAAP profit of $0.60 per share was 34.8% above analysts’ consensus estimates.
Is now the time to buy PLAB? Find out in our full research report (it’s free for active Edge members).
Photronics’ third quarter was marked by heightened demand for advanced integrated circuit (IC) photomasks and robust execution in the U.S. and Asia, driving results above Wall Street expectations. Management credited the outperformance to a record mix of high-end IC orders, particularly in the U.S., and a favorable shift in product mix. CEO George Makrokostas highlighted increased outsourcing opportunities from traditional captive mask makers and a growing presence in AI-driven packaging, reinforcing the company’s position in critical market segments. Management also noted that capacity expansions at key facilities underpinned the improved performance.
Looking ahead, Photronics’ guidance reflects expectations of sustained high-end photomask demand, supported by ongoing geographic expansion and industry trends like advanced node migration and regional reshoring of semiconductor manufacturing. Management stated that investments in the U.S. and Korea will broaden exposure to leading-edge chip designs, with CEO George Makrokostas emphasizing the company’s intent to "capitalize on growth trends including increased captive outsourcing, high-end node migrations, and geographic supply chain diversity." The leadership team also indicated that new production capabilities are expected to drive incremental revenue and margin improvements as customer demand for advanced chips continues to rise.
Management attributed the quarter’s results to a strong shift toward high-end IC photomasks, increased outsourcing from captives, and a diversified customer base, especially in the U.S. and Asia.
Management expects future performance to be shaped by continued demand for advanced photomasks, regional manufacturing trends, and expanded production capacity.
In the coming quarters, the StockStory team will monitor (1) progress on capacity expansions in Texas and Korea as signposts for future revenue contribution, (2) the pace of high-end photomask adoption in advanced applications including AI and regional reshoring efforts, and (3) the company’s ability to offset mainstream IC softness by further penetrating high-margin, advanced segments. Developments in the outsourcing trend among large semiconductor manufacturers will also be a key indicator.
Photronics currently trades at $36.98, up from $25.69 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free for active Edge members).
The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
| 3 hours | |
| 5 hours | |
| 9 hours | |
| 10 hours | |
| 18 hours | |
| Dec-10 | |
| Dec-10 | |
| Dec-10 | |
| Dec-10 | |
| Dec-10 | |
| Dec-10 | |
| Dec-10 | |
| Dec-10 | |
| Dec-10 | |
| Dec-10 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite